Thermo Fisher presented multicenter data showing its Oncomine Comprehensive Assay Plus running on the automated Ion Torrent Genexus platform can deliver comprehensive genomic profiling (CGP) with next‑day turnaround and minimal hands‑on time. The amplicon‑based assay interrogates 517 genes and complex signatures (TMB, MSI) and previously demonstrated >95% concordance with orthogonal methods on the GeneStudio system. Company speakers framed automation and low sample input requirements as solutions to CGP bottlenecks in clinical labs. Widespread adoption will depend on clinical validation, reimbursement pathways, and integration into tumor‑board workflows.